# pathway_0155: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/pathway_0155.txt)

**Task:** `pathway`  
**Author key, unchanged:** **B** — Antifungal biosynthesis. .

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | usable output (valid_review) |
| after | GPT-6 Luna | supported | reasoning-supported | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MSLQPTATEVGTMYDQYTSLLTDVMAGFIHVGYWDDPEREDTIEVATERLTREIGERLSSVRGQRILDVGCGTGKSAVQIATAHDVHITGITVSNHQIELAQSQYESNTKAGQVNFLFANAMDLPFADASFDGAYAIESLVHMDDRRTALTNIARVLRPGSRLAIADLFLDAGCPNPEVLARFHELFQVPPMPSGDDLKALLHQTGFKVIEFTDIRDTSGLSANF

[Multiple Choices]
A. L-fucose degradation. .
B. Antifungal biosynthesis. .
C. chorismate biosynthesis
D. L-homoserine from L-aspartate: step 2/3. .
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence matches the UniProt record for an O-methyltransferase in the restricticin biosynthesis cluster, which annotates its pathway as antifungal biosynthesis. The pathway annotation cites experimental evidence, although the underlying paper was not independently reviewed here.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence may suggest a methyltransferase, but that alone does not establish which specific biosynthetic pathway it serves.


**Missing item-specific fact**

> The protein's association with the restricticin/antifungal biosynthetic cluster and its pathway annotation.


**Reason**

> Distinguishing antifungal biosynthesis from the listed alternatives requires protein-specific pathway knowledge absent from the sequence and choices; recognizing the exact database entry would be lookup or memorization, not sequence-based reasoning.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The matched, cited pathway annotation supports choice B; the supplied evidence does not identify another listed option as a pathway for this protein.


### Important caveats

- The database record and sequence match support the expected answer, but the primary study was not independently examined.
- Reviewer-only accession and annotation information was not provided to the evaluated model.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence may suggest a methyltransferase, but that alone does not establish which specific biosynthetic pathway it serves.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein's association with the restricticin/antifungal biosynthetic cluster and its pathway annotation.",
    "reason": "Distinguishing antifungal biosynthesis from the listed alternatives requires protein-specific pathway knowledge absent from the sequence and choices; recognizing the exact database entry would be lookup or memorization, not sequence-based reasoning."
  },
  "case_id": "pathway_0155",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "C6",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The sequence matches the UniProt record for an O-methyltransferase in the restricticin biosynthesis cluster, which annotates its pathway as antifungal biosynthesis. The pathway annotation cites experimental evidence, although the underlying paper was not independently reviewed here."
  },
  "important_caveats": [
    "The database record and sequence match support the expected answer, but the primary study was not independently examined.",
    "Reviewer-only accession and annotation information was not provided to the evaluated model."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The matched, cited pathway annotation supports choice B; the supplied evidence does not identify another listed option as a pathway for this protein."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0155",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence matches the UniProt record for an O-methyltransferase in the restricticin biosynthesis cluster, which annotates its pathway as antifungal biosynthesis. The pathway annotation cites experimental evidence, although the underlying paper was not independently reviewed here.",
    "evidence_ids": ["C4", "C5", "C6", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence may suggest a methyltransferase, but that alone does not establish which specific biosynthetic pathway it serves.",
    "missing_item_specific_fact": "The protein's association with the restricticin/antifungal biosynthetic cluster and its pathway annotation.",
    "reason": "Distinguishing antifungal biosynthesis from the listed alternatives requires protein-specific pathway knowledge absent from the sequence and choices; recognizing the exact database entry would be lookup or memorization, not sequence-based reasoning."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The matched, cited pathway annotation supports choice B; the supplied evidence does not identify another listed option as a pathway for this protein."
  },
  "important_caveats": [
    "The database record and sequence match support the expected answer, but the primary study was not independently examined.",
    "Reviewer-only accession and annotation information was not provided to the evaluated model."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry A0A0L1JF88 (RSTN1_ASPN3) matches the supplied 225-aa sequence exactly (SHA256 confirmed). The entry carries an explicit PATHWAY annotation 'Antifungal biosynthesis' with evidence code ECO:0000269 (inferred from direct assay) from PubMed 33857369 (Liu et al., JACS 2021). The protein is annotated as O-methyltransferase rstn1 / Restricticin biosynthesis cluster protein 1 (EC 2.1.1.-), a component of the restricticin biosynthetic gene cluster in Aspergillus nomiae. Choice B matches the curated pathway annotation precisely.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H1](#evidence-h1), [H2](#evidence-h2), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence contains a 'GCGTGKSAV' motif (GxGxG) characteristic of Rossmann-fold methyltransferases, which could narrow the enzymatic class. However, methyltransferases participate in dozens of pathways. None of the four pathway choices can be uniquely inferred from the sequence alone: the motif does not encode information about restricticin biosynthesis, antifungal secondary metabolism, or the specific biosynthetic gene cluster. Distinguishing 'Antifungal biosynthesis' from 'L-fucose degradation' or 'chorismate biosynthesis' requires knowing that this particular methyltransferase (Rstn1) is a member of the restricticin BGC in Aspergillus nomiae.


**Missing item-specific fact**

> The specific identity of this protein as Rstn1, a methyltransferase within the restricticin (an antifungal CYP51-inhibitor) biosynthetic gene cluster of Aspergillus nomiae, as characterized experimentally in Liu et al. 2021 (JACS 143:6043-6047). Without this protein-specific annotation, the sequence provides no pathway-level discriminant among the four choices.


**Reason**

> General biological knowledge can identify the protein as a methyltransferase from the GCGTGKSAV motif, but cannot assign it to 'Antifungal biosynthesis' rather than any other pathway. The correct answer depends on recalling or looking up the specific UniProt/functional annotation of this particular protein.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Given the specific UniProt annotation, only B is correct. The other three choices (L-fucose degradation, chorismate biosynthesis, L-homoserine from L-aspartate step 2/3) describe primary metabolic pathways whose canonical enzymes (kinases, dehydrogenases, aldolases, dehydratases) are mechanistically and structurally distinct from an O-methyltransferase of this size and fold. No other option is defensible once the protein's true identity is known.


### Important caveats

- The pathway annotation 'Antifungal biosynthesis' is a UniProt-curated category applied to secondary-metabolite BGCs producing antifungal compounds; it is not a standard KEGG or MetaCyc pathway name, which may confuse models expecting canonical pathway nomenclature.
- The evidence code ECO:0000269 indicates experimental support (direct assay from the 2021 JACS paper), not purely computational transfer.
- The evaluated model receives only the raw sequence and four choices; the UniProt accession, organism, and gene name are absent from the input.
- The entry was first released in Swiss-Prot on 2025-02-05; whether the benchmark authors had access to this annotation at construction time is unknown.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains a 'GCGTGKSAV' motif (GxGxG) characteristic of Rossmann-fold methyltransferases, which could narrow the enzymatic class. However, methyltransferases participate in dozens of pathways. None of the four pathway choices can be uniquely inferred from the sequence alone: the motif does not encode information about restricticin biosynthesis, antifungal secondary metabolism, or the specific biosynthetic gene cluster. Distinguishing 'Antifungal biosynthesis' from 'L-fucose degradation' or 'chorismate biosynthesis' requires knowing that this particular methyltransferase (Rstn1) is a member of the restricticin BGC in Aspergillus nomiae.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The specific identity of this protein as Rstn1, a methyltransferase within the restricticin (an antifungal CYP51-inhibitor) biosynthetic gene cluster of Aspergillus nomiae, as characterized experimentally in Liu et al. 2021 (JACS 143:6043-6047). Without this protein-specific annotation, the sequence provides no pathway-level discriminant among the four choices.",
    "reason": "General biological knowledge can identify the protein as a methyltransferase from the GCGTGKSAV motif, but cannot assign it to 'Antifungal biosynthesis' rather than any other pathway. The correct answer depends on recalling or looking up the specific UniProt/functional annotation of this particular protein."
  },
  "case_id": "pathway_0155",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "C6",
      "H1",
      "H2",
      "H3"
    ],
    "judgment": "supported",
    "reason": "UniProt entry A0A0L1JF88 (RSTN1_ASPN3) matches the supplied 225-aa sequence exactly (SHA256 confirmed). The entry carries an explicit PATHWAY annotation 'Antifungal biosynthesis' with evidence code ECO:0000269 (inferred from direct assay) from PubMed 33857369 (Liu et al., JACS 2021). The protein is annotated as O-methyltransferase rstn1 / Restricticin biosynthesis cluster protein 1 (EC 2.1.1.-), a component of the restricticin biosynthetic gene cluster in Aspergillus nomiae. Choice B matches the curated pathway annotation precisely."
  },
  "important_caveats": [
    "The pathway annotation 'Antifungal biosynthesis' is a UniProt-curated category applied to secondary-metabolite BGCs producing antifungal compounds; it is not a standard KEGG or MetaCyc pathway name, which may confuse models expecting canonical pathway nomenclature.",
    "The evidence code ECO:0000269 indicates experimental support (direct assay from the 2021 JACS paper), not purely computational transfer.",
    "The evaluated model receives only the raw sequence and four choices; the UniProt accession, organism, and gene name are absent from the input.",
    "The entry was first released in Swiss-Prot on 2025-02-05; whether the benchmark authors had access to this annotation at construction time is unknown."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Given the specific UniProt annotation, only B is correct. The other three choices (L-fucose degradation, chorismate biosynthesis, L-homoserine from L-aspartate step 2/3) describe primary metabolic pathways whose canonical enzymes (kinases, dehydrogenases, aldolases, dehydratases) are mechanistically and structurally distinct from an O-methyltransferase of this size and fold. No other option is defensible once the protein's true identity is known."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0155",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry A0A0L1JF88 (RSTN1_ASPN3) matches the supplied 225-aa sequence exactly (SHA256 confirmed). The entry carries an explicit PATHWAY annotation 'Antifungal biosynthesis' with evidence code ECO:0000269 (inferred from direct assay) from PubMed 33857369 (Liu et al., JACS 2021). The protein is annotated as O-methyltransferase rstn1 / Restricticin biosynthesis cluster protein 1 (EC 2.1.1.-), a component of the restricticin biosynthetic gene cluster in Aspergillus nomiae. Choice B matches the curated pathway annotation precisely.",
    "evidence_ids": ["C1", "C4", "C5", "C6", "H1", "H2", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence contains a 'GCGTGKSAV' motif (GxGxG) characteristic of Rossmann-fold methyltransferases, which could narrow the enzymatic class. However, methyltransferases participate in dozens of pathways. None of the four pathway choices can be uniquely inferred from the sequence alone: the motif does not encode information about restricticin biosynthesis, antifungal secondary metabolism, or the specific biosynthetic gene cluster. Distinguishing 'Antifungal biosynthesis' from 'L-fucose degradation' or 'chorismate biosynthesis' requires knowing that this particular methyltransferase (Rstn1) is a member of the restricticin BGC in Aspergillus nomiae.",
    "missing_item_specific_fact": "The specific identity of this protein as Rstn1, a methyltransferase within the restricticin (an antifungal CYP51-inhibitor) biosynthetic gene cluster of Aspergillus nomiae, as characterized experimentally in Liu et al. 2021 (JACS 143:6043-6047). Without this protein-specific annotation, the sequence provides no pathway-level discriminant among the four choices.",
    "reason": "General biological knowledge can identify the protein as a methyltransferase from the GCGTGKSAV motif, but cannot assign it to 'Antifungal biosynthesis' rather than any other pathway. The correct answer depends on recalling or looking up the specific UniProt/functional annotation of this particular protein."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Given the specific UniProt annotation, only B is correct. The other three choices (L-fucose degradation, chorismate biosynthesis, L-homoserine from L-aspartate step 2/3) describe primary metabolic pathways whose canonical enzymes (kinases, dehydrogenases, aldolases, dehydratases) are mechanistically and structurally distinct from an O-methyltransferase of this size and fold. No other option is defensible once the protein's true identity is known."
  },
  "important_caveats": [
    "The pathway annotation 'Antifungal biosynthesis' is a UniProt-curated category applied to secondary-metabolite BGCs producing antifungal compounds; it is not a standard KEGG or MetaCyc pathway name, which may confuse models expecting canonical pathway nomenclature.",
    "The evidence code ECO:0000269 indicates experimental support (direct assay from the 2021 JACS paper), not purely computational transfer.",
    "The evaluated model receives only the raw sequence and four choices; the UniProt accession, organism, and gene name are absent from the input.",
    "The entry was first released in Swiss-Prot on 2025-02-05; whether the benchmark authors had access to this annotation at construction time is unknown."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence-matched UniProt pathway annotation identifies antifungal biosynthesis and cites experimental evidence (ECO:0000269). This supports the keyed pathway, though the excerpt does not independently describe the underlying experiment.

Citations as saved: [C5](#evidence-c5).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains a glycine-rich motif consistent with SAM binding in a small methyltransferase. A methyltransferase is a plausible tailoring enzyme in specialized antifungal biosynthesis, whereas the other choices describe pathways whose named steps are not methyl-transfer reactions. This provides a meaningful, probabilistic basis for choosing B among these options.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> The pathway is not uniquely determined by the motif alone, but transferable knowledge about SAM-dependent methyltransferases and pathway chemistry distinguishes B from the offered alternatives.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The sequence-based family inference and the listed pathway chemistries favor B over the alternatives.


### Important caveats

- A SAM-binding methyltransferase motif does not by itself establish the enzyme's exact substrate or pathway.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains a glycine-rich motif consistent with SAM binding in a small methyltransferase. A methyltransferase is a plausible tailoring enzyme in specialized antifungal biosynthesis, whereas the other choices describe pathways whose named steps are not methyl-transfer reactions. This provides a meaningful, probabilistic basis for choosing B among these options.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "The pathway is not uniquely determined by the motif alone, but transferable knowledge about SAM-dependent methyltransferases and pathway chemistry distinguishes B from the offered alternatives."
  },
  "case_id": "pathway_0155",
  "expected_answer_check": {
    "evidence_ids": [
      "C5"
    ],
    "judgment": "supported",
    "reason": "The sequence-matched UniProt pathway annotation identifies antifungal biosynthesis and cites experimental evidence (ECO:0000269). This supports the keyed pathway, though the excerpt does not independently describe the underlying experiment."
  },
  "important_caveats": [
    "A SAM-binding methyltransferase motif does not by itself establish the enzyme's exact substrate or pathway."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The sequence-based family inference and the listed pathway chemistries favor B over the alternatives."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0155",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence-matched UniProt pathway annotation identifies antifungal biosynthesis and cites experimental evidence (ECO:0000269). This supports the keyed pathway, though the excerpt does not independently describe the underlying experiment.",
    "evidence_ids": ["C5"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains a glycine-rich motif consistent with SAM binding in a small methyltransferase. A methyltransferase is a plausible tailoring enzyme in specialized antifungal biosynthesis, whereas the other choices describe pathways whose named steps are not methyl-transfer reactions. This provides a meaningful, probabilistic basis for choosing B among these options.",
    "missing_item_specific_fact": "",
    "reason": "The pathway is not uniquely determined by the motif alone, but transferable knowledge about SAM-dependent methyltransferases and pathway chemistry distinguishes B from the offered alternatives."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The sequence-based family inference and the listed pathway chemistries favor B over the alternatives."
  },
  "important_caveats": [
    "A SAM-binding methyltransferase motif does not by itself establish the enzyme's exact substrate or pathway."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry for this sequence (A0A0L1JF88, RSTN1_ASPN3) explicitly annotates the pathway as 'Antifungal biosynthesis' with evidence code ECO:0000269 (inferred from direct assay, PubMed:33857369). The protein is an O-methyltransferase in the restricticin biosynthesis gene cluster; restricticin is a natural-product CYP51 inhibitor with antifungal activity. The annotation is experimentally supported.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [C4](#evidence-c4), [C6](#evidence-c6).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains the motif 'VGCGTGKSAV' (GxGxxG pattern), a well-known Rossmann-fold signature characteristic of class I methyltransferases. This is standard transferable biochemistry knowledge. Applying this to the four choices: (A) L-fucose degradation involves fucose isomerase, fucokinase, and fuculose-1-phosphate aldolase — none are Rossmann-fold methyltransferases. (C) Chorismate biosynthesis involves DAHP synthase, DHQ synthase, shikimate dehydrogenase, shikimate kinase, EPSP synthase, and chorismate synthase — none are methyltransferases. (D) L-homoserine from L-aspartate step 2/3 is homoserine dehydrogenase, which IS a Rossmann-fold NAD(P)-dependent dehydrogenase, but it is typically ≥350–400 amino acids and contains additional regulatory domains; the 225-aa size and the specific motif context (GCGTGKSA rather than the catalytic Ser/Thr position-2 variant typical of dehydrogenases) are more consistent with a standalone methyltransferase. By elimination of A, C, and D on enzyme-family grounds, B ('Antifungal biosynthesis') remains as the only option compatible with a small fungal methyltransferase involved in secondary-metabolite tailoring. This is a legitimate family-level inference from transferable knowledge of enzyme folds and pathway enzyme inventories.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> The GxGxxG Rossmann-fold motif is a widely taught sequence signature. Knowing which enzyme types populate each listed pathway (isomerases/kinases/aldolases for fucose; synthases/dehydrogenases/kinases for chorismate; a large dehydrogenase for homoserine) allows elimination of A, C, and D. The 225-aa size further disfavors homoserine dehydrogenase. The remaining option B is broad enough to encompass a fungal methyltransferase in a natural-product biosynthetic cluster. The inference relies on general enzyme-family and pathway knowledge, not on recalling this specific protein's annotation.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The three distractors (A, C, D) name specific pathways whose constituent enzymes are well-characterized and structurally distinct from a small Rossmann-fold methyltransferase. 'Antifungal biosynthesis' (B) is a broad UniProt pathway category that encompasses tailoring enzymes including methyltransferases in fungal secondary-metabolite clusters, making it the only compatible choice after elimination.


### Important caveats

- The GxGxxG motif identifies a Rossmann fold but does not uniquely prove methyltransferase activity from sequence alone; the inference also relies on protein size and motif context.
- 'Antifungal biosynthesis' is a UniProt-specific pathway vocabulary term; a model unfamiliar with this exact nomenclature might find option B unusual, though elimination of A/C/D still points to it.
- The reviewer-only evidence confirms the annotation is experimentally supported (ECO:0000269), but this information was not available to the evaluated model.
- The argument that homoserine dehydrogenase is too large (≥350 aa) for a 225-aa protein is a reasonable size-based exclusion but is not an absolute proof; some truncated or engineered variants exist.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains the motif 'VGCGTGKSAV' (GxGxxG pattern), a well-known Rossmann-fold signature characteristic of class I methyltransferases. This is standard transferable biochemistry knowledge. Applying this to the four choices: (A) L-fucose degradation involves fucose isomerase, fucokinase, and fuculose-1-phosphate aldolase — none are Rossmann-fold methyltransferases. (C) Chorismate biosynthesis involves DAHP synthase, DHQ synthase, shikimate dehydrogenase, shikimate kinase, EPSP synthase, and chorismate synthase — none are methyltransferases. (D) L-homoserine from L-aspartate step 2/3 is homoserine dehydrogenase, which IS a Rossmann-fold NAD(P)-dependent dehydrogenase, but it is typically ≥350–400 amino acids and contains additional regulatory domains; the 225-aa size and the specific motif context (GCGTGKSA rather than the catalytic Ser/Thr position-2 variant typical of dehydrogenases) are more consistent with a standalone methyltransferase. By elimination of A, C, and D on enzyme-family grounds, B ('Antifungal biosynthesis') remains as the only option compatible with a small fungal methyltransferase involved in secondary-metabolite tailoring. This is a legitimate family-level inference from transferable knowledge of enzyme folds and pathway enzyme inventories.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "The GxGxxG Rossmann-fold motif is a widely taught sequence signature. Knowing which enzyme types populate each listed pathway (isomerases/kinases/aldolases for fucose; synthases/dehydrogenases/kinases for chorismate; a large dehydrogenase for homoserine) allows elimination of A, C, and D. The 225-aa size further disfavors homoserine dehydrogenase. The remaining option B is broad enough to encompass a fungal methyltransferase in a natural-product biosynthetic cluster. The inference relies on general enzyme-family and pathway knowledge, not on recalling this specific protein's annotation."
  },
  "case_id": "pathway_0155",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "C4",
      "C6"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry for this sequence (A0A0L1JF88, RSTN1_ASPN3) explicitly annotates the pathway as 'Antifungal biosynthesis' with evidence code ECO:0000269 (inferred from direct assay, PubMed:33857369). The protein is an O-methyltransferase in the restricticin biosynthesis gene cluster; restricticin is a natural-product CYP51 inhibitor with antifungal activity. The annotation is experimentally supported."
  },
  "important_caveats": [
    "The GxGxxG motif identifies a Rossmann fold but does not uniquely prove methyltransferase activity from sequence alone; the inference also relies on protein size and motif context.",
    "'Antifungal biosynthesis' is a UniProt-specific pathway vocabulary term; a model unfamiliar with this exact nomenclature might find option B unusual, though elimination of A/C/D still points to it.",
    "The reviewer-only evidence confirms the annotation is experimentally supported (ECO:0000269), but this information was not available to the evaluated model.",
    "The argument that homoserine dehydrogenase is too large (≥350 aa) for a 225-aa protein is a reasonable size-based exclusion but is not an absolute proof; some truncated or engineered variants exist."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The three distractors (A, C, D) name specific pathways whose constituent enzymes are well-characterized and structurally distinct from a small Rossmann-fold methyltransferase. 'Antifungal biosynthesis' (B) is a broad UniProt pathway category that encompasses tailoring enzymes including methyltransferases in fungal secondary-metabolite clusters, making it the only compatible choice after elimination."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0155",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry for this sequence (A0A0L1JF88, RSTN1_ASPN3) explicitly annotates the pathway as 'Antifungal biosynthesis' with evidence code ECO:0000269 (inferred from direct assay, PubMed:33857369). The protein is an O-methyltransferase in the restricticin biosynthesis gene cluster; restricticin is a natural-product CYP51 inhibitor with antifungal activity. The annotation is experimentally supported.",
    "evidence_ids": ["C5", "H3", "C4", "C6"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains the motif 'VGCGTGKSAV' (GxGxxG pattern), a well-known Rossmann-fold signature characteristic of class I methyltransferases. This is standard transferable biochemistry knowledge. Applying this to the four choices: (A) L-fucose degradation involves fucose isomerase, fucokinase, and fuculose-1-phosphate aldolase — none are Rossmann-fold methyltransferases. (C) Chorismate biosynthesis involves DAHP synthase, DHQ synthase, shikimate dehydrogenase, shikimate kinase, EPSP synthase, and chorismate synthase — none are methyltransferases. (D) L-homoserine from L-aspartate step 2/3 is homoserine dehydrogenase, which IS a Rossmann-fold NAD(P)-dependent dehydrogenase, but it is typically ≥350–400 amino acids and contains additional regulatory domains; the 225-aa size and the specific motif context (GCGTGKSA rather than the catalytic Ser/Thr position-2 variant typical of dehydrogenases) are more consistent with a standalone methyltransferase. By elimination of A, C, and D on enzyme-family grounds, B ('Antifungal biosynthesis') remains as the only option compatible with a small fungal methyltransferase involved in secondary-metabolite tailoring. This is a legitimate family-level inference from transferable knowledge of enzyme folds and pathway enzyme inventories.",
    "missing_item_specific_fact": "",
    "reason": "The GxGxxG Rossmann-fold motif is a widely taught sequence signature. Knowing which enzyme types populate each listed pathway (isomerases/kinases/aldolases for fucose; synthases/dehydrogenases/kinases for chorismate; a large dehydrogenase for homoserine) allows elimination of A, C, and D. The 225-aa size further disfavors homoserine dehydrogenase. The remaining option B is broad enough to encompass a fungal methyltransferase in a natural-product biosynthetic cluster. The inference relies on general enzyme-family and pathway knowledge, not on recalling this specific protein's annotation."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The three distractors (A, C, D) name specific pathways whose constituent enzymes are well-characterized and structurally distinct from a small Rossmann-fold methyltransferase. 'Antifungal biosynthesis' (B) is a broad UniProt pathway category that encompasses tailoring enzymes including methyltransferases in fungal secondary-metabolite clusters, making it the only compatible choice after elimination."
  },
  "important_caveats": [
    "The GxGxxG motif identifies a Rossmann fold but does not uniquely prove methyltransferase activity from sequence alone; the inference also relies on protein size and motif context.",
    "'Antifungal biosynthesis' is a UniProt-specific pathway vocabulary term; a model unfamiliar with this exact nomenclature might find option B unusual, though elimination of A/C/D still points to it.",
    "The reviewer-only evidence confirms the annotation is experimentally supported (ECO:0000269), but this information was not available to the evaluated model.",
    "The argument that homoserine dehydrogenase is too large (≥350 aa) for a 225-aa protein is a reasonable size-based exclusion but is not an absolute proof; some truncated or engineered variants exist."
  ]
}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "A0A0L1JF88",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "c81f547e718f545a528716fcbb0efd66301f895b7a6e7743da00b44566669860",
  "benchmark_sequence_length": 225,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 25,
    "firstPublicDate": "2025-02-05",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2015-11-11",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "dda8c813658a8c709826544ad5ddbd2ae972d7bfe23bb0ae87e41d05627a6d20",
  "current_source_sequence_sha256": "c81f547e718f545a528716fcbb0efd66301f895b7a6e7743da00b44566669860",
  "current_source_sequence_length": 225,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 23,
  "selected_historical_version": {
    "accession": "A0A0L1JF88",
    "database": "Swiss-Prot",
    "entryVersion": 23,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_01/2026_01",
    "lastReleaseDate": "28-Jan-2026",
    "name": "RSTN1_ASPN3",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "79e66fc3e8c4ef26bf02567903ff65dcc83c5c855359b04ab315caa7a97c6612",
  "selected_historical_source_sequence_sha256": "c81f547e718f545a528716fcbb0efd66301f895b7a6e7743da00b44566669860",
  "selected_historical_source_sequence_length": 225,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 23,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A0L1JF88.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A0L1JF88.json",
  "source_sha256": "dda8c813658a8c709826544ad5ddbd2ae972d7bfe23bb0ae87e41d05627a6d20",
  "retrieved_utc": "2026-11-02T04:24:15.624587+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"A0A0L1JF88\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A0L1JF88.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A0L1JF88.json",
  "source_sha256": "dda8c813658a8c709826544ad5ddbd2ae972d7bfe23bb0ae87e41d05627a6d20",
  "retrieved_utc": "2026-11-02T04:24:15.624587+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":25,\"firstPublicDate\":\"2025-02-05\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2015-11-11\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A0L1JF88.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A0L1JF88.json",
  "source_sha256": "dda8c813658a8c709826544ad5ddbd2ae972d7bfe23bb0ae87e41d05627a6d20",
  "retrieved_utc": "2026-11-02T04:24:15.624587+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"lineage\":[\"Eukaryota\",\"Fungi\",\"Dikarya\",\"Ascomycota\",\"Pezizomycotina\",\"Eurotiomycetes\",\"Eurotiomycetidae\",\"Eurotiales\",\"Aspergillaceae\",\"Aspergillus\",\"Circumdati\"],\"scientificName\":\"Aspergillus nomiae NRRL (strain ATCC 15546 / NRRL 13137 / CBS 260.88 / M93)\",\"taxonId\":1509407}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A0L1JF88.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A0L1JF88.json",
  "source_sha256": "dda8c813658a8c709826544ad5ddbd2ae972d7bfe23bb0ae87e41d05627a6d20",
  "retrieved_utc": "2026-11-02T04:24:15.624587+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"33857369\",\"source\":\"PubMed\"}],\"value\":\"Restricticin biosynthesis cluster protein 1\"}}],\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"33857369\",\"source\":\"PubMed\"}],\"value\":\"2.1.1.-\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"33857369\",\"source\":\"PubMed\"}],\"value\":\"O-methyltransferase rstn1\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A0L1JF88.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A0L1JF88.json",
  "source_sha256": "dda8c813658a8c709826544ad5ddbd2ae972d7bfe23bb0ae87e41d05627a6d20",
  "retrieved_utc": "2026-11-02T04:24:15.624587+00:00",
  "json_pointer": "/comments/3",
  "excerpt": "{\"commentType\":\"PATHWAY\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"33857369\",\"source\":\"PubMed\"}],\"value\":\"Antifungal biosynthesis\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A0L1JF88.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A0L1JF88.json",
  "source_sha256": "dda8c813658a8c709826544ad5ddbd2ae972d7bfe23bb0ae87e41d05627a6d20",
  "retrieved_utc": "2026-11-02T04:24:15.624587+00:00",
  "json_pointer": "/references/1",
  "excerpt": "{\"citation\":{\"authors\":[\"Liu N.\",\"Abramyan E.D.\",\"Cheng W.\",\"Perlatti B.\",\"Harvey C.J.B.\",\"Bills G.F.\",\"Tang Y.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"33857369\"},{\"database\":\"DOI\",\"id\":\"10.1021/jacs.1c01516\"}],\"citationType\":\"journal article\",\"firstPage\":\"6043\",\"id\":\"33857369\",\"journal\":\"J. Am. Chem. Soc.\",\"lastPage\":\"6047\",\"publicationDate\":\"2021\",\"title\":\"Targeted genome mining reveals the biosynthetic gene clusters of natural product CYP51 inhibitors.\",\"volume\":\"143\"},\"referenceNumber\":2,\"referencePositions\":[\"FUNCTION\",\"CATALYTIC ACTIVITY\",\"BIOPHYSICOCHEMICAL PROPERTIES\",\"PATHWAY\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A0L1JF88?format=txt&versions=23)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A0L1JF88?format=txt&versions=23",
  "source_sha256": "79e66fc3e8c4ef26bf02567903ff65dcc83c5c855359b04ab315caa7a97c6612",
  "retrieved_utc": "2026-11-02T04:24:17.437797+00:00",
  "source_locator": "lines 1-15",
  "excerpt": "ID   RSTN1_ASPN3             Reviewed;         225 AA.\nAC   A0A0L1JF88;\nDT   05-FEB-2025, integrated into UniProtKB/Swiss-Prot.\nDT   11-NOV-2015, sequence version 1.\nDT   28-JAN-2026, entry version 23.\nDE   RecName: Full=O-methyltransferase rstn1 {ECO:0000303|PubMed:33857369};\nDE            EC=2.1.1.- {ECO:0000269|PubMed:33857369};\nDE   AltName: Full=Restricticin biosynthesis cluster protein 1 {ECO:0000303|PubMed:33857369};\nGN   Name=rstn1 {ECO:0000303|PubMed:33857369}; ORFNames=ANOM_001442;\nOS   Aspergillus nomiae NRRL (strain ATCC 15546 / NRRL 13137 / CBS 260.88 /\nOS   M93).\nOC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;\nOC   Eurotiomycetidae; Eurotiales; Aspergillaceae; Aspergillus;\nOC   Aspergillus subgen. Circumdati.\nOX   NCBI_TaxID=1509407;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 23,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A0L1JF88?format=txt&versions=23)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A0L1JF88?format=txt&versions=23",
  "source_sha256": "79e66fc3e8c4ef26bf02567903ff65dcc83c5c855359b04ab315caa7a97c6612",
  "retrieved_utc": "2026-11-02T04:24:17.437797+00:00",
  "source_locator": "lines 24-31",
  "excerpt": "RN   [2]\nRP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND PATHWAY.\nRX   PubMed=33857369; DOI=10.1021/jacs.1c01516;\nRA   Liu N., Abramyan E.D., Cheng W., Perlatti B., Harvey C.J.B., Bills G.F.,\nRA   Tang Y.;\nRT   \"Targeted genome mining reveals the biosynthetic gene clusters of natural\nRT   product CYP51 inhibitors.\";\nRL   J. Am. Chem. Soc. 143:6043-6047(2021).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 23,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A0L1JF88?format=txt&versions=23)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A0L1JF88?format=txt&versions=23",
  "source_sha256": "79e66fc3e8c4ef26bf02567903ff65dcc83c5c855359b04ab315caa7a97c6612",
  "retrieved_utc": "2026-11-02T04:24:17.437797+00:00",
  "source_locator": "lines 60-60",
  "excerpt": "CC   -!- PATHWAY: Antifungal biosynthesis. {ECO:0000269|PubMed:33857369}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 23,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 155. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
